广发纳斯达克生物科技人民币(001092)

动态评分: 2.62分

投资组合

报告日期 名称 比例
2016-12-31 Prothena Corp plc 0.27%
2016-12-31 Radius Health Inc 0.26%
2016-12-31 Theravance Biopharma Inc 0.26%
2016-12-31 Spark Therapeutics Inc 0.24%
2016-12-31 Sarepta Therapeutics Inc 0.24%
2016-12-31 Array BioPharma Inc 0.23%
2016-12-31 Five Prime Therapeutics Inc 0.23%
2016-12-31 莱斯康制药 0.23%
2016-12-31 AveXis Inc 0.21%
2016-12-31 FibroGen Inc 0.21%
2016-12-31 Aerie Pharmaceuticals Inc 0.2%
2016-12-31 奥洛兹美医疗 0.2%
2016-12-31 Portola Pharmaceuticals Inc 0.2%
2016-12-31 Supernus Pharmaceuticals Inc 0.2%
2016-12-31 AMAG Pharmaceutical Inc 0.19%
2016-12-31 Coherus BioSciences Inc 0.19%
2016-12-31 Eagle制药 0.19%
2016-12-31 NantHealth Inc 0.19%
2016-12-31 Pacira BioSciences Inc 0.19%
2016-12-31 Assertio Holdings Inc 0.18%

投资模拟

公告&资料